Researchers from the Johns Hopkins Kimmel Cancer Center have developed an artificial intelligence-based blood test that can detect liver cancer . The algorithm, called DELFI (DNA evaluation of fragments for early interception), looks for changes in DNA fragments that are shed by cancer cells, known as cell-free DNA (cfDNA), into the bloodstream and generates a DELFI score. The new technology presents a promising approach for the early detection of hepatocellular carcinoma. Researchers have expressed that the approach needs to be validated in larger studies before clinical use. How can artificial intelligence algorithms improve cancer care?
Share your views by commenting below. ##Reference## Foda ZH, Annapragada AV, Boyapati K, Bruhm DC, Vulpescu NA, Medina JE, Mathios D, Cristiano S, Niknafs N, Luu HT, Goggins MG. Detecting liver cancer using cell-free DNA fragmentomes. Cancer…
